Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Details)

v3.19.3
Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 7,271 $ 10,119
Employee compensation and benefits 3,323 2,985
Professional fees 549 618
Facilities and other 61 171
Total accrued expenses $ 11,204 $ 13,893